COMPARISON OF 2 FLUOROCHROMES FOR FLOW CYTOMETRIC ASSAY OF CELLULAR GLUTATHIONE CONTENT IN HUMAN-MALIGNANT MELANOMA

被引：18

作者：

COATES, A

TRIPP, E

机构：

[1] Sydney Melanoma Unit Laboratory, University of Sydney, Royal Prince Alfred Hospital, Camperdown, NSW

来源：

MELANOMA RESEARCH | 1995年 / 5卷 / 02期

关键词：

ANALYTICAL FLOW CYTOMETRY; CHLOROMETHYL FLUORESCEIN DIACETATE; DRUG RESISTANCE; FINE-NEEDLE ASPIRATION BIOPSY; GLUTATHIONE; METASTASIS; MERCURY ORANGE;

D O I：

10.1097/00008390-199504000-00006

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Because the resistance of melanoma to cytotoxic therapy may be due to high intracellular glutathione (GSH), we wished to monitor GSH in melanoma cells during treatment. This required an assay suitable for very small samples. So we chose analytical flow cytometry. We calibrated the flow cytometric assays against biochemically determined GSH content in a range of cultured human melanoma cell lines, then applied the assays to fine-needle tumour biopsies. Mercury orange was the first fluorochrome suitable for use in a flow cytometer with a 488 nm light source, but many technical factors influenced the results. Chloromethyl fluorescein diacetate (CMFDA) allowed assay conditions less dependent on details of cell handling. Correlations between biochemical GSH content and fluorescence intensities in cell lines were good for mercury orange and CMFDA. CMFDA is the preferred fluorochrome for estimating cellular GSH content in biopsies from human melanomas. Tumours metastatic to or beyond regional lymph nodes had significantly more cells with high GSH than primary tumours or regional recurrences.

引用

页码：107 / 111

页数：5

共 27 条

[1]

Coates A.S., Systemic chemotherapy for malignant melanoma, World J Surg, 16, pp. 277-281, (1992)

[2]

Coates A.S., Durant J.R., Chemotherapy for metastatic melanoma. In: Balch CM, Milton GW (eds), Cutaneous Melanoma. Clinical Management and Results Worldwide, pp. 275-282, (1985)

[3]

Thompson J.F., Gianoutsos M.P., Isolated limb perfusion for melanoma: Effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs, World J Surg, 16, pp. 227-233, (1992)

[4]

Coates A.S., Tripp E., Glutathione content of human malignant melanoma cell lines: Correlation of flow cytometric and biochemical assays and application to human tumour aspirates, Melanoma Res, 1, pp. 327-332, (1991)

[5]

Benathan M., Alvero-Jackson H., Mooy A.M., Scaletta C., Frenk E., Relationship between melanogenesis, glutathione levels and melphalan toxicity in human melanoma cells, Melanoma Res, 2, pp. 305-314, (1992)

[6]

Chakraborty A.K., Ueda M., Mishima Y., Ichihashi M., Intracellular glutathione and its metabolizing enzyme activities in a metastatic variant melanoma cell line, Melanoma Res, 2, pp. 315-319, (1992)

[7]

Arrick B., Nathan C.F., Glutathione metabolism as a determinant of therapeutic efficacy: A review, Cancer Res, 44, pp. 4232-4244, (1984)

[8]

Thrall B.D., Factors involved in the inherent resistance of malignant melanoma cells to cytotoxic drugs, Diss Abstr Lnt [B], 51, (1991)

[9]

Barhoumi R., Bowen J.A., Stein L.S., Echols J., Burghardt R.C., Concurrent analysis of intracellular glutathione and gap junction intercellular communication, Cytometry, 14, pp. 747-756, (1993)

[10]

O'connor J.E., Kimler B.F., Morgan M.C., Tempas K., A flow cytometric assay for intracellular nonprotein thiols using mercury orange, Cytometry, 9, pp. 529-532, (1988)

← 1 2 3 →